NYSE: DVA
DaVita Inc.
Healthcare · Medical - Care Facilities
After hours: $211.38(+1.67%) · as of 6:57 PM ET
Market Cap
$13.34B
52w High
$213.44
52w Low
$101.00
P/E
18.33
Volume
578.40K
Outstanding Shares
64.19M
Valuation Data Insufficient
The DCF model's fair value estimate is more than 3× the current stock price. This typically indicates unreliable model inputs — such as irregular cash flows or balance sheet distortions — rather than a genuine opportunity, so the valuation is not shown.
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 53.11% over the last year. Revenue grew 6.68% over the trailing twelve months. Operating margin moved from 15.77% to 15.01%. Free cash flow declined 15.15% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 15.01%. A decisive move in revenue — currently up 6.68% — would be the clearest signal to resolve the ambiguity.
Company profile
DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure.
Valuation
Stock splits
Every 1 shares became 2
Every 2 shares became 3
Every 3 shares became 5
Profitability & growth
Analyst consensus
9
Buy
13
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 5, 2026
Q3 FY26 · EPS est $3.84 · Revenue est $3.5B
View